Sanders MacHelle
CIK 0001718020
Director
Filings
14
Latest Nov 17, 2025
Issuers covered
4
Showing
14 of 14
Page 1
Track record
3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | -5.5% | -10.0% | +9.9% | -16.5% |
| 90 days | 3 | 67% | -4.0% | +0.9% | +13.8% | -26.8% |
| 180 days | 3 | 33% | -7.2% | -19.6% | +25.4% | -27.5% |
| 365 days | 2 | 50% | -18.5% | -18.5% | +22.7% | -59.8% |
Issuers
Companies where Sanders MacHelle has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | 7 | Nov 17, 2025 |
| FTRE | Fortrea Holdings Inc. | 3 | Jun 12, 2025 |
| NOVN | Novan, Inc. | 3 | Jun 27, 2023 |
| RDUS | Radius Health, Inc. | 1 | Jan 25, 2022 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|